针对B细胞瘤的免疫疗法BAFF的现状
Nami Tagami1, Junichiro Yuda2, Yasuyuki Goto3
1Laboratory of Molecular Immunology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan.
International journal of clinical oncology
|September 2, 2024
概括
B细胞激活因子 (BAFF) 对B细胞的发育和生存至关重要. 准BAFF及其受体为血液恶性瘤提供了有前途的治疗策略,目前正在进行的临床试验评估其潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- B细胞激活因子 (BAFF),也称为B淋巴细胞刺激剂 (BLyS),是TNF超级家族中的关键细胞因子.
- BAFF通过其受体 (BCMA,TACI,BAFF-R) 影响B细胞的发育,增殖,免疫球蛋白分泌和生存.
- BAFF的失调与自身免疫性疾病和血液性恶性瘤有关,影响B细胞群和疾病进展.
研究的目的:
- 审查BAFF及其受体在血液恶性瘤的背景下的多方面的作用.
- 探索针对BAFF及其信号通路治疗B细胞相关癌症的治疗潜力.
- 总结目前的临床试验数据和BAFF向治疗的临床前发现.
主要方法:
- 关于BAFF功能,其受体及其在血液恶性瘤中的参与研究的文献综述.
- 对BAFF向治疗的临床试验数据的分析,如贝利马布,阿塔西塞普和塔巴马布.
- 检查关于新方法的临床前研究,例如基于BAFF联体的CAR-T细胞.
主要成果:
- 缺乏BAFF的小鼠表现出受损的幽默反应,而BAFF过度表达可以导致淋巴增殖障碍和自身免疫表现.
- 升高的BAFF水平与某些血液性恶性瘤的疾病进展相关.
- 临床试验显示,针对BAFF向疗法的疗效各不相同;贝利穆马布和阿塔西塞普特正在对CLL进行研究,而tabalumab在多发性骨髓瘤中表现出有限的成功.
结论:
- BAFF在B细胞平衡中起着至关重要的作用,并与血液性恶性瘤的发病有关.
- 准BAFF及其受体代表了对B细胞恶性瘤的有前途的治疗策略.
- 进一步的研究和临床试验对于优化BAFF向治疗和了解它们对瘤微环境的影响至关重要.
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493